baber/WOPTO huggingface dataset:
Patent CA-2680911-C (CA)
Inventor: HAROS HERNANDEZ ALFREDO
IPC: H02G15/00
Filed: 2009-09-29
Granted: 2014-01-28
Abstract: A device for maintaining the separation and position of spliced wires within a mold is provided. The device is characterized by multiple pointed portions which extend radially outward to a tip. The portions between the tips are radially depressed, with holes placed near the radially innermost point of the outer surface of the device. The holes are incomplete due to notches on the radially outermost portion of the holes which allow wires to be pressed into the holes in a radially inward direction. The device, with wires mounted therein, may be placed into an injection mold and maintains the separation of the exposed conductors until the over-molding process is complete. The device also prevents the wires from touching the edge of the mold during the injection process thereby minimizing any show-through defects in the finished product.
Patent CA-2683514-C (CA)
Title: Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
Inventor: BISHOP CHARLES W
IPC: A61K31/59
Filed: 2008-04-25
Granted: 2019-07-09
Abstract: A method of treating and preventing secondary hyperparathyroidism in CKD by increasing or maintaining blood concentrations of both 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in a patient by administering 25-hydroxyvitamin D3 with or without 25-hydroxyvitamin D2 and, as necessary, 1,25-dihydroxyvitamin D2 as a Vitamin D hormone replacement therapy.
Patent CA-2684292-C (CA)
Title: Systeme et procede permettant de surveiller l'etat physique d'un equipement de puits de production et de reguler la production du puits de production
Inventor: THIGPEN BRIAN L
IPC: E21B43/12
Filed: 2008-04-18
Granted: 2012-12-11
Abstract: L'invention porte sur un système et un procédé qui permettent de produire un fluide à partir d'un puits complété, lequel procédé consiste, dans un aspect, à : déterminer un premier réglage d'au moins un premier dispositif qui est utilisé pour produire le fluide à partir du puits; choisir un premier ensemble de paramètres d'entrée comprenant au moins un paramètre lié à l'état de fonctionnement d'un second dispositif au moins et une pluralité de paramètres choisis dans un groupe composé d'informations liées au débit, à la pression, la température, à la présence d'une substance chimique choisie, la teneur en eau, la teneur en sable, et la vitesse d'injection chimique; utiliser le premier ensemble de paramètres choisi comme entrée d'un modèle informatique; déterminer un second réglage du premier dispositif précité qui permettra d'augmenter la durée de vie utile du second dispositif et/ou d'améliorer le débit de fluide en provenance du puits complété.
Patent CA-2685881-C (CA)
Inventor: WIMMER ECKHARD
IPC: B66C23/62
Filed: 2008-04-14
Granted: 2012-08-07
Abstract: The invention herein relates to an arrangement with a winch for hoisting loads and adjusting mechanism for the winch, wherein the winch when being assembled on a crane arm can be moved to a limited extent between a working position and a transport position by way of the adjusting mechanism, the adjusting mechanism comprising at least one liner drive which interacts with a lever apparatus in order to adjust a winch, the lever apparatus comprising at least one knee lever.
Patent CA-2686093-C (CA)
Inventor: SINGH PARMINDER
IPC: A61M37/00
Filed: 2008-04-16
Granted: 2018-05-08
Abstract: In an aspect of the invention, an array of microprotrusions is formed by providing a mold with cavities corresponding to the negative of the microprotrusions, casting atop the mold a first solution comprising a biocompatible material and a solvent, removing the solvent, casting a second solution atop the first cast solution, removing the solvent from the second solution, and demolding the resulting array from the mold. The first solution preferably contains an active ingredient.
Patent CA-2687227-C (CA)
Inventor: PARRAMON JORDI
IPC: A61N1/378
Filed: 2008-06-25
Granted: 2014-04-15
Abstract: An improved arbitration scheme for allowing concurrent stimulation and telemetry listening in a microstimulator is disclosed. A listening window for telemetry is permitted to proceed, and access to the microstimulator' s coil granted, during at least a portion of the inter-pulse period that follows the issuance of a stimulation pulse. This is permissible because access to the coil is not needed during the entirety of the inter-pulse period. For example, the listening window can issue during that portion of the inter-pulse period when the decoupling capacitor is discharged, but cannot issue during that portion of the inter-pulse period when the compliance voltage is being generated for the next stimulation pulse. However, because compliance voltage generation occupies only a small portion of the inter-pulse period, the technique is not substantially limited. By allowing the listening window to issue during the majority of the inter-pulse period, the listening window produces smaller gaps between the pulses, and stimulation therapy is thus brought closer to its ideal.
Patent CA-2687965-C (CA)
Title: Interface de guide d'ions multipolaire pour une reduction du bruit de fond en spectrometrie de masse
Inventor: WHITEHOUSE CRAIG M
IPC: H01J49/42
Filed: 2008-05-28
Granted: 2015-11-24
Abstract: Les ions qui sont transportés d'une source d'ions vers un spectromètre de masse pour une analyse de masse sont souvent accompagnés de particules résiduelles telles que des photons, des espèces neutres et des ions en grappes ou en aérosol, qui prennent naissance dans la source d'ions. Des particules résiduelles sont également produites par diffusion et neutralisation d'ions au cours de collisions avec des molécules de gaz résiduelles dans des zones de haute pression avec visibilité directe vers le détecteur du spectromètre de masse. Dans les deux cas, de telles particules résiduelles produisent du bruit dans les spectres de masse. L'invention concerne un appareil et des procédés selon lesquels un guide d'ions multipolaire est configuré de façon à transporter efficacement des ions au fil de plusieurs étages de vide, tout en empêchant les particules résiduelles, produites à la fois dans la source d'ions et sur le trajet de transport des ions, d'atteindre le détecteur, améliorant ainsi le rapport signal-bruit dans les spectres de masse.
Patent CA-2688474-C (CA)
Title: Absorbent articles comprising low basis weight films exhibiting low glue burn through
Inventor: DENT TERRA LOUISE
IPC: C08J5/18
Filed: 2008-06-05
Granted: 2013-09-03
Abstract: Low basis weight films having a heat capacity x density value of greater than about 970,00 Ws/m3K, as measured by the method described herein, the films having a basis weight of less than about 16gsm and comprising a least about 10% polypropylene
Patent CA-2690945-C (CA)
Title: Composition pharmaceutique transdermique ou transmuqueuse comprenant 1-(benzofuran-2-yl)-2-propylaminopentane
Inventor: YONEDA FUMIO
IPC: A61K9/70
Filed: 2008-06-20
Granted: 2015-07-21
Abstract: Le problème à résoudre dans le cadre de la présente invention consiste à fournir une composition destinée à être administrée par voie transdermique ou transmucosale qui est utile en tant que médicament contre la maladie d'Alzheimer, médicament contre la maladie de Parkinson, médicament antidépresseur, médicament psychotrope, remède contre la pharmacodépendance ou autre chose similaire. La solution proposée consiste en une composition destinée à être administrée par voie transdermique ou transmucosale qui contient - une quantité efficace d'un corps racémique ou isomère optiquement actif de 1-(benzofuran-2-yl)-2-propylaminopentane ou son sel pharmacologiquement acceptable et - un vecteur et qui peut être administrée sans être invasive pour la peau ou la muqueuse, est excellente en tant que médicament contre la maladie d'Alzheimer, médicament contre la maladie de Parkinson, médicament antidépresseur, médicament psychotrope ou remède contre la pharmacodépendance, étant donné que la composition permet l'accès stable d'une quantité efficace d'ingrédient actif dans le corps ou le cerveau via la peau ou la muqueuse sans causer de troubles tels qu'une perte dans l'ingrédient actif causé par l'effet de premier passage dans le foi, une douleur, une blessure ou une infection.
Patent CA-2691580-C (CA)
Inventor: SCHILLING KRISTIAN
IPC: A61K51/12
Filed: 2008-06-20
Granted: 2015-11-24
Abstract: The invention relates to pharmaceutical agents containing a particulate inorganic matrix having a diameter of from 0.1 nm to 100 µm, preferably 1 nm to 10 µm, particularly preferably 1 nm to 1 µm, such as, for example, topaz, (Al2F2)[SiO4], and chiolite, Na[Al3F4], preferably wavellite, Al3(PO4)2(OH, F)2, calcium carbonate, CaCO3, maghemite, Y-Fe2O3, particularly preferably zeolites, gen. formula Mn[(AlO2)x(SiO2)y](M = metal, e.g. Na), magnetite, Fe3O4, and barium sulphate, BaSO4, and very particularly preferably gallium phosphate, GaPO4, apatite or fluorohydroxyapatite, Ca5(PO4)3(OH, F) = 3Ca3(PO4)2 * Ca(OH, F)2, and fluorspar, CaF2, which, in addition to the natural isotope distribution of the structure type--forming elements of the anions and cations, also contain medically usable contents of positron-emitting nuclides, such as, for example, [15]O, [30]P, [13]N, preferably [65]Ga, [11]C, particularly preferably [131]Ba, [26]Al, and very particularly preferably [68]Ga and [18]F, the preparation thereof, and the use of these composition in medicine, particularly preferably in diagnostic imaging, in particular positron emission tomography (PET), on animals and humans, and in vitro diagnostics.
Patent CA-2691912-C (CA)
Inventor: GRASMANN JOSEF
IPC: G09F9/37
Filed: 2008-07-04
Granted: 2013-03-12
Abstract: A setting apparatus (1) for displacing push elements (5) in a sign display module (4), with the push elements (5) each being held in the display ducts (6) of the sign display module (4) and being displaceable from a first position in which the face surfaces (5a) of the push elements (5) are visible on a display surface (7) of the sign display module (4) to a second position in which said face surfaces (5a) are arranged substantially in a non-visible way at a distance behind the display surface (7) in the sign display module (4). In order to enable a flexible and rapid setting of a sequence of signs of random length on a sign display module, at least one receptacle (8) is provided in accordance with the invention for the sign display module (4) to be set and a setting means (3) is arranged in the receptacle (8) which causes the displacement of the push elements (5) during the insertion of the sign display module (4) into the receptacle (8).
Patent CA-2701924-C (CA)
Title: Configuration de terminal d'acces et commande d'acces
Inventor: GUPTA RAJARSHI
IPC: H04W48/14
Filed: 2008-10-07
Granted: 2018-04-03
Abstract: La présente invention concerne la fourniture et le contrôle d'accès destinés à des nuds de communication impliquant l'attribution d'identificateurs à des ensembles de nuds, lesquels identificateurs peuvent être utilisés pour contrôler l'accès à des nuds d'accès restreints qui fournissent certains services uniquement à certains ensembles de nuds définis. Dans certains modes de réalisation, l'approvisionnement d'un nud peut impliquer la fourniture d'un identificateur unique pour des ensembles d'un ou de plusieurs nuds tels que des points d'accès restreints et des terminaux d'accès autorisés à recevoir un service de la part des points d'accès restreints. Le contrôle d'accès peut être fourni au moyen d'un point d'accès restreint et/ou d'un nud de réseau. Dans certains modes de réalisation, l'approvisionnement d'un nud implique de fournir une liste d'itinérance préférée pour le nud. Dans certains modes de réalisation, un nud peut recevoir une liste d'itinérance préférée via l'utilisation d'une balise d'amorce.
Patent CA-2703818-C (CA)
Inventor: KABARADJIAN CATHERINE
IPC: A23L27/00
Filed: 2008-10-21
Granted: 2016-01-05
Abstract: The present invention relates to an orodispersible composition without bad odour, smell or taste comprising polyunsaturated fatty acids (PUFA), its process for preparation and its use as nutritional supplement or as dietary supplement for balancing the blood lipid level, preventing or reducing the risk of the development of atherosclerotic changes, disorders or diseases.
Patent CA-2709831-C (CA)
Inventor: URSEM WILLIBRORDUS NICOLAAS JOHANNES
IPC: E01H13/00
Filed: 2008-12-17
Granted: 2016-06-21
Abstract: The invention provides the use, a method, and an apparatus to reduce and remove liquid droplets in air, such as fog, mist, or haze, although the invention in specific embodiments might also be used to reduce and remove liquid droplets from a spray or steam.The invention of the mist and/or air borne water or other liquid droplets catching and collection apparatus creates an electric wind, especially enforced by charged needle points or line arranged constructions and/or wires of the first electrode and an electric charging of mist and/or air borne water or other liquid droplets, which will be directed by the electric wind and the electric field between the electric source and the opposite grounded or opposite charged counter electrode (second electrode) of fine gauze or something comparable.
Patent CA-2710348-C (CA)
Inventor: ARMSTRONG JOSEPH R
IPC: A61F2/966
Filed: 2005-07-08
Granted: 2013-01-22
Abstract: A constraining sheath for use around an endoprosthesis (e.g., a sent device, with or without a graft covering), which may be a balloon expandable endoprosthesis but more preferably is a self-expanding prosthesis. The endoprosthesis is coaxially enclosed within and substantially covered by the constraining sheath, which is an outer, removable tubular sheath, preferably made of ePTFE. The sheath is preferably corrugated circumferentially along at least a portion of the length of the endoprosthesis. The constraining sheath and endoprosthesis are preferably mounted together as an assembly at the distal end of a delivery means such as a catheter shaft, for delivery of the endoprosthesis to a desired location within a body conduit such as an artery. The constraining sheath is removed by the application of tension to a tensile member such as a tether to cause sequential pulling out of the corrugations followed by release and deployment of the endoprosthesis. The use of a corrugated constraining sheath in comparison to a non-corrugated sheath results in a more smoothly applied tensile force to effect the endoprosthesis release as well as requiring less maximum force.
Patent CA-2712623-C (CA)
Inventor: KOWOLL JOHANNES
IPC: C10J3/52
Filed: 2009-01-21
Granted: 2016-03-08
Abstract: A method for removing slag accumulating in particular during synthesis gas recovery from slag present in a pressurized container bath in a collecting tank for the slag, in the direction of gravity under the slag bath, wherein optionally a mechanism for breaking the slag is provided under the slag bath and a sluice valve is provided between the containers, is to clearly improve the corresponding processes and plants of the relevant kinds by improving withdrawal of slag and by preventing environmentally harmful exhaust vapors or waste gases. This is achieved in that a space that is in contact with the liquid in the containers and is filled with a gas bubble is provided, in particular an annular space or a separate container, in which the pressure of the gas bubble is controlled by gas supply such that at least part of the water present in the slag sluice/collection space flows through the slag bath valve against the direction of gravity in the direction of the slag bath when the slag bath valve is opened.
Patent CA-2713150-C (CA)
Inventor: NEUFER P DARRELL
IPC: A61K38/07
Filed: 2009-02-06
Granted: 2016-01-05
Abstract: The invention provides methods of preventing or treating insulin resistance in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide having at least one net positive charge;  a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (p m) and the total number of amino acid residues (r) wherein 3p m is the largest number that is less than or equal to r +  1; and a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (p) where-in 2a is the largest number that is less than or equal to p t + 1, except that when a is 1, p t may also be 1.
Patent CA-2714695-C (CA)
Inventor: KLASSEN GERHARD DIETRICH
IPC: G01P15/16
Filed: 2010-09-09
Granted: 2016-08-09
Abstract: The disclosure is directed to a method, computer program product, mobile device or a system allowing for determining various route metrics (142) based on stored route records (132) associated with routes traversed by the mobile device. The determination of a route metric may utilize processing (140) of a single route record or multiple route records. Exemplary route metrics (142) include route timing metrics such as lap times, or route record metrics. Configurations of computer program products, mobile devices and systems for enabling the determination of various route metrics are also described.
Patent CA-2717161-C (CA)
Title: Combinaison de surveillance electronique d'article/d'antenne d'identification de radiofrequence
Inventor: LEONE STEVEN V
IPC: H01Q9/04
Filed: 2009-03-05
Granted: 2016-09-06
Abstract: La présente invention concerne une antenne de combinaison EAS/RFID utilisée dans un système de surveillance EAS/RFID. Lantenne comprend un élément dantenne EAS et un élément dantenne RFID. Lélément dantenne EAS comprend une antenne cadre EAS définissant une partie intérieure. Lélément dantenne RFID comprend une antenne de correction RFID ayant un schéma conducteur hachuré. Lélément dantenne RFID est situé à proximité de lantenne cadre EAS de façon à réduire la taille densemble de lantenne.
Patent CA-2718494-C (CA)
Inventor: HORMANN ROBERT E
IPC: C07J9/00
Filed: 2009-03-16
Granted: 2016-05-17
Abstract: The present invention relates to steroidal ligands for use in nuclear receptor-based inducible gene expression systems.  The invention further relates to methods of modulating the expression of genes of interest with a system containing one or more nuclear receptor complexes and one or more steroidal ligands. Further aspects include ligand compositions including therapeutic compositions.
Patent CA-2726469-C (CA)
Inventor: BODUM JORGEN
IPC: A47J31/20
Filed: 2009-05-08
Granted: 2016-02-02
Abstract: The invention discloses a plunger-filter be-verage-making machine with a lid which can be closed by a valve. The beverage-making machine has a vessel (2), a lid (3) and a filter piston (4) which can be vertically displaced in the vessel and has a piston rod (41). The lid (3) contains a pouring opening (37) which can be closed by means of an elongate lever (33) which extends transverse to the pi-ston rod. To this end, the lever is mounted on the lid such that it can pivot about a horizontal axis. The lever has, in the region of its front end, a closure body (36) in order to close the pouring opening and, in the region of its rear end, an operating region (331) in order to pivot the lever by vir-tue of pressure exerted by a finger of a user.
Patent CA-2731140-C (CA)
Title: A method for measuring adjacent areas
Inventor: CHEN LIPING
IPC: H04W36/24
Filed: 2009-07-17
Granted: 2017-03-21
Abstract: The present invention discloses a method for measuring adjacent cells, and the method is used for measuring adjacent cells by using dormant idle sub-frames to receive specified data from a network side in an idle state, and adjacent cells are measured by using an idle window to receive the specified data from the network side in a connection state. The present invention realizes measurement of the TD-SCDMA adjacent cells in a WCDMA mode and measurement of the WCDMA adjacent cells in a TD-SCDMA mode; and further more achieves reselection and switching from WCDMA to TD-SCDMA  adjacent cell and from the TD-SCDMA to WCDMA adjacent cell on this basis, meets a real-time requirement effectively, and has high practical value.
Patent CA-2735023-C (CA)
Inventor: TURVEY ROBERT R
IPC: A47G25/48
Filed: 2011-03-24
Granted: 2014-01-07
Abstract: A two-piece hanger for hanging a bag filled with contents without puncturing the bag holds the bag between the two pieces with a cleat-and-groove connection. The hanger includes a hanger piece for hanging from a support and a clamping piece that is removably attachable to the hanger piece. The hanger piece includes a hanger mechanism and a cleat. The clamping piece includes a body having an upper surface and a slotted grove receptor. The clamping piece is removably connected to the hanger piece by inserting the head of the cleat into the slotted grove receptor, whereby the cleat locks the clamping piece to the body of the hanger member in a cleat-and-groove arrangement.
Patent CA-2736130-C (CA)
Inventor: WHITE RYAN
IPC: A61K31/429
Filed: 2009-09-11
Granted: 2014-01-14
Abstract: The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula (I); wherein A1, A2, A3, A4, A5, A6, T1, T2, W, X, Y and Z of Formula (I) are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimer's Disease, cognitive deficits, cognitive impairment, schizophrenia and other central nervous system conditions related to and/or caused by the formation and/or deposition of plaque on the brain.  The invention also comprises further embodiments of Formula I, intermediates and processes useful for the preparation of compounds of Formula (I).
Patent CA-2736971-C (CA)
Inventor: GREIG IAIN ROBERT
IPC: C07D213/52
Filed: 2009-09-18
Granted: 2017-06-20
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as "APSAC  compounds"). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. Formula (I).
Patent CA-2740296-C (CA)
Inventor: KELLY PETER M
IPC: H04R5/033
Filed: 2011-01-06
Granted: 2018-05-01
Abstract: A set of headphones designed to be used by DJ's for the purpose of mixing two or more music tracks being played from two or more audio playing devices.  The headphones arc configured such that a DJ can easily mute one headphone speaker so that the DJ can listen to a first music track that is being played through a sound system. At the same time, the headphones are configured to direct the complete stereo signal to the other headphone speaker so that the DJ can listen to the complete audio from a second music track. For example, when the DJ presses an audio control button, the set of headphones can automatically mute one of the speakers on the headphones, and automatically direct all of the stereo channels to the opposing speaker on the set of headphones.